Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
Go back to Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 53.66 +2.36 (4.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.30 | 52 Week High | $45.58 | |||
| Open | $52.42 | 52 Week Low | $37.82 | |||
| Day High | $53.84 | P/E | N/A | |||
| Day Low | $52.25 | EPS | $0.00 | |||
| Volume | 3,802,645 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 19.28 +1.08 (5.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.20 | 52 Week High | $63.73 | |||
| Open | $18.41 | 52 Week Low | $8.00 | |||
| Day High | $19.56 | P/E | N/A | |||
| Day Low | $18.03 | EPS | $-5.69 | |||
| Volume | 4,787,545 | |||||
